Open AccessRole of Co-Infection in the Immunopathology of COVID-19 in pregnancy
Author(s) -
Ahmed M. Abbas,
Shimaa Salah,
Safaa Fathy,
Alaa Rashad,
Asmaa Abobakr,
Ebrahim Ahmed Yousof,
Ahmed Saeed,
Elza Youssef Youssef,
Asmaa S. Shaltout,
Omar Ahmed
Publication year - 2020
Publication title -
archives of health science
Language(s) - English
Resource type - Journals
ISSN - 2641-7456
DOI - 10.31829/2641-7456/ahs2020-4(1)-117
Subject(s) - pregnancy , immune system , immunology , covid-19 , viral infection , medicine , disease , infectious disease (medical specialty) , biology , virus , genetics
“Co-infection” differs from single infection mainly in the effect of co-infection on the host health which may be harmful, beneficial or absent. This effect occurs mainly due to changes in host immune response. Co-infection is used in treatment of other diseases not just infectious ones. It’s well known that co-infection may have beneficial effects that can improve overall outcome better than single agent infection especially in case of viruses. There are many immunological mechanisms to achieve that. As co-infection has a beneficial effect that we may use it in treatment, there is harmful effect that we should avoid. In this review we tried to evaluate the effect of co-infection in pregnancy with coronavirus disease-2019 (COVID-19) and how the immune system of the pregnant women will respond to co-infection.